Premium
[P2–098]: TSPO IMMUNOSTAINING IN AD CASES WITH/WITHOUT AN AD‐ASSOCIATED TREM2 VARIANT
Author(s) -
Hodges Angela,
Lim Yau Mun
Publication year - 2017
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2017.06.747
Subject(s) - microglia , trem2 , translocator protein , neuroinflammation , pathology , immunohistochemistry , immunostaining , neurodegeneration , biology , medicine , immunology , disease , inflammation
Figure 2. Reported cerebrospinal fluid levels of Ab42 peptide, total tau (T-tau), and phospho-tau (P-tau) protein in the index case are consistent with the diagnosis of AD. (A) Technical results reported from Athena Diagnostics. (B) Subject data is plotted on the graph to illustrate the position of the individual’s results relative to recognized reference points for diagnostic cutoff values. Poster Presentations: Monday, July 17, 2017 P644